Marco Sisignano

15PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsMolecular targetsPredictive and prognostic markersComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 26, 2026
Lysophospholipid-TRPV1 interactions in chemotherapy-induced neuropathy.

|Sep 18, 2025
Topical Analgesics: Pharmacology and Clinical Applications.

Marco Sisignano, Andrew S C Rice, Gerd Geisslinger

|Mar 13, 2025
Ocular Surface Changes Differ Significantly Between Oxaliplatin- and Diabetes-Induced Polyneuropathy.

Martin Schicht, Marco Sisignano, Jessica Farger

|Sep 30, 2024
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients.

Jörn Lötsch, Khayal Gasimli, Sebastian Malkusch

|Dec 04, 2023
Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins.

Cosmin Trif, Alexandra-Maria Banica, Alexandra Manolache

|Nov 26, 2022
The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury.

Saskia Wedel, Lisa Hahnefeld, Mohamad Wessam Alnouri

Pageof 3

Frequent Collaborators

1 joint publications

Seungkyu Lee

1 joint publications

Tabea Osthues

1 joint publications

Kevin Klann

1 joint publications

Andreas Weigert